Skip to main content
Emergent BioSolutions Inc. logo

Emergent BioSolutions Inc. — Investor Relations & Filings

Ticker · EBS ISIN · US29089Q1058 LEI · 549300YW6TUOX8BE5103 US Manufacturing
Open in API
Filings indexed 1,264 across all filing types
Latest filing 2010-03-03 Board/Management Inform…
Country US United States of America
Listing US EBS

About Emergent BioSolutions Inc.

https://emergentbiosolutions.com/

Emergent BioSolutions Inc. is a life sciences company specializing in solutions for public health threats. The company develops, manufactures, and delivers medical countermeasures for national security and public health preparedness, addressing threats such as anthrax, smallpox, botulism, and Ebola. In addition to its biodefense portfolio, Emergent provides commercial products for endemic health crises, notably the opioid epidemic. The company also offers contract development and manufacturing services through strategic partnerships, leveraging its specialized capabilities to support biopharmaceutical innovators, governments, and non-governmental organizations.

Recent filings

Filing Released Lang Actions
8-K Filing
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The content focuses on the adoption of an Annual Bonus Plan for executive officers and the establishment of corporate and individual goals for 2010. It details management compensation arrangements and changes related to executive officers. There are no financial statements or comprehensive financial data presented, so it is not an Annual Report (10-K) or Interim Report (IR). It is not a full Management Discussion & Analysis (MDA) but rather an announcement of management compensation plans. The key item is "Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers," which aligns with Board/Management Information filings. Therefore, the appropriate classification is MANG (Board/Management Information). The document length is under 5,000 characters, but it is not merely announcing a report publication; it contains substantive information about management compensation plans.
2010-03-03 English
4/A Filing
Director's Dealing
2010-02-03 English
SC 13G Filing
Major Shareholding Notification
2010-01-25 English
8-K Filing
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content details the entry into a new loan agreement, termination of a prior loan agreement, and creation of a new financial obligation. These are updates on financing activities and capital structure changes. There are no financial statements or comprehensive financial data presented, only descriptions of financing agreements and terms. Therefore, this document fits the category of Capital/Financing Update (CAP). The document length is over 6000 characters, indicating it is a full report rather than a brief announcement or certification. Hence, the classification is CAP with high confidence.
2010-01-06 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.